These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9950255)
21. Enhanced cell death in NR-S1 tumor by photodynamic therapy: possible involvement of Fas and Fas ligand system. Yokota T; Ikeda H; Inokuchi T; Sano K; Koji T Lasers Surg Med; 2000; 26(5):449-60. PubMed ID: 10861700 [TBL] [Abstract][Full Text] [Related]
22. Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade. Doll C; Arsenic R; Lage H; Jöhrens K; Hartwig S; Nelson K; Raguse JD Anticancer Res; 2015 Nov; 35(11):5867-72. PubMed ID: 26504009 [TBL] [Abstract][Full Text] [Related]
23. Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas. Mustafa T; Eckert A; Klonisch T; Kehlen A; Maurer P; Klintschar M; Erhuma M; Zschoyan R; Gimm O; Dralle H; Schubert J; Hoang-Vu C Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):108-19. PubMed ID: 15668483 [TBL] [Abstract][Full Text] [Related]
24. Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes. Silva SD; Cunha IW; Rangel AL; Jorge J; Zecchin KG; Agostini M; Kowalski LP; Coletta RD; Graner E Virchows Arch; 2008 Jul; 453(1):57-67. PubMed ID: 18528705 [TBL] [Abstract][Full Text] [Related]
25. Pressure and endothelial coculture upregulate myocytic Fas-FasL pathway and induce apoptosis by way of direct and paracrine mechanisms. Vouyouka AG; Lin L; Basson MD Am J Surg; 2005 Nov; 190(5):780-6. PubMed ID: 16226958 [TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells. Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285 [TBL] [Abstract][Full Text] [Related]
27. Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study. Kaur G; Carnelio S; Rao N; Rao L Indian J Dent Res; 2009; 20(1):71-6. PubMed ID: 19336864 [TBL] [Abstract][Full Text] [Related]
28. Fas ligand upregulation is an early event in colonic carcinogenesis. Bennett MW; O'Connell J; Houston A; Kelly J; O'Sullivan GC; Collins JK; Shanahan F J Clin Pathol; 2001 Aug; 54(8):598-604. PubMed ID: 11477113 [TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma. de Sousa SO; Mesquita RA; Pinto DS; Gutkind S J Oral Pathol Med; 2002 Feb; 31(2):78-81. PubMed ID: 11896827 [TBL] [Abstract][Full Text] [Related]
30. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
31. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC). Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896 [TBL] [Abstract][Full Text] [Related]
32. Mechanism of counterattack of colorectal cancer cell by Fas/Fas ligand system. Zhu Q; Liu JY; Xu HW; Yang CM; Zhang AZ; Cui Y; Wang HB World J Gastroenterol; 2005 Oct; 11(39):6125-9. PubMed ID: 16273638 [TBL] [Abstract][Full Text] [Related]
33. Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis. Rigberg DA; Centeno J; Kim FS; Ke B; Swenson K; Maggard M; McFadden DW J Surg Oncol; 1999 Jun; 71(2):91-6. PubMed ID: 10389864 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells by phosphatidylinositol 3-kinase inhibitor. Kondo G; Iwase M; Watanabe H; Uchida M; Takaoka S; Ohashi M; Nagumo M Oral Oncol; 2006 Aug; 42(7):745-52. PubMed ID: 16527514 [TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/APO2L) and its receptors expression in human squamous cell carcinoma of the oral cavity. Fukuda M; Hamao A; Tanaka A; Kitada M; Suzuki S; Kusama K; Sakashita H Oncol Rep; 2003; 10(5):1113-9. PubMed ID: 12883666 [TBL] [Abstract][Full Text] [Related]
36. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma]. Liu YM; Huang JH; Feng DY; Guo XC Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962 [TBL] [Abstract][Full Text] [Related]
37. Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas. Kase S; Osaki M; Adachi H; Kaibara N; Ito H Int J Oncol; 2002 Feb; 20(2):291-7. PubMed ID: 11788891 [TBL] [Abstract][Full Text] [Related]
38. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma. Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229 [TBL] [Abstract][Full Text] [Related]
39. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844 [TBL] [Abstract][Full Text] [Related]
40. Alteration of Fas/FasL expression of oral squamous cell carcinoma cell line Tca83 induced by retinoic acid. Guan WQ; Yu SF; Gao Y Chin J Dent Res; 2000 Dec; 3(4):35-9. PubMed ID: 11314085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]